COVID-19 时代肝癌放射治疗的角色转变
The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era.
作者信息
Li Zheng, Hu Yue, Zeng Ming, Hu Qinyong, Ye Fei, Liu Ruifeng, Cai Hongyi, Li Qiang, Wang Xiaohu
机构信息
Institute of Modern Physics, Chinese Academy of Sciences, Lanzhou, China.
Lanzhou Heavy Ion Hospital, Lanzhou, China.
出版信息
Front Oncol. 2022 Sep 14;12:976143. doi: 10.3389/fonc.2022.976143. eCollection 2022.
Abstract
The uncontrollable COVID-19 crises in the SARS-CoV-2 high-prevalence areas have greatly disrupted the routine treatment of liver cancer and triggered a role transformation of radiotherapy for liver cancer. The weight of radiotherapy in the treatment algorithm for liver cancer has been enlarged by the COVID-19 pandemic, which is helpful for the optimal risk-benefit profile.
摘要
在严重急性呼吸综合征冠状病毒2（SARS-CoV-2）高流行地区，无法控制的新型冠状病毒肺炎（COVID-19）危机极大地扰乱了肝癌的常规治疗，并引发了肝癌放疗角色的转变。COVID-19大流行增加了放疗在肝癌治疗方案中的权重，这有助于实现最佳的风险效益比。
相似文献
1
The role transition of radiotherapy for the treatment of liver cancer in the COVID-19 era.
Front Oncol. 2022 Sep 14;12:976143. doi: 10.3389/fonc.2022.976143. eCollection 2022.
2
Carbon Ion Radiotherapy Acts as the Optimal Treatment Strategy for Unresectable Liver Cancer During the Coronavirus Disease 2019 Crisis.
Front Public Health. 2021 Dec 9;9:767617. doi: 10.3389/fpubh.2021.767617. eCollection 2021.
3
Gynecologic cancer surveillance in the era of SARS-CoV-2 (COVID-19).
Int J Gynecol Cancer. 2021 Jun;31(6):914-919. doi: 10.1136/ijgc-2020-001942. Epub 2020 Oct 5.
4
Digital cardiovascular care in COVID-19 pandemic: A potential alternative?
J Card Surg. 2020 Dec;35(12):3545-3550. doi: 10.1111/jocs.15094. Epub 2020 Oct 10.
5
COVID-19 and radiotherapy: potential new strategies for patients management with hypofractionation and telemedicine.
Eur Rev Med Pharmacol Sci. 2020 Dec;24(23):12480-12489. doi: 10.26355/eurrev_202012_24044.
6
Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement.
Radiother Oncol. 2020 May;146:223-229. doi: 10.1016/j.radonc.2020.04.001. Epub 2020 Apr 6.
7
Patient-reported outcomes and complications during head and neck cancer radiotherapy before versus during the COVID-19 pandemic.
Support Care Cancer. 2022 Mar;30(3):2745-2753. doi: 10.1007/s00520-021-06703-x. Epub 2021 Nov 26.
8
Clinical examination practices and perceptions in the era of COVID-19.
Expert Rev Respir Med. 2021 Aug;15(8):967-971. doi: 10.1080/17476348.2021.1941884. Epub 2021 Jun 17.
9
Cancer Australia consensus statement on COVID-19 and cancer care: embedding high value changes in practice.
Med J Aust. 2021 Nov 15;215(10):479-484. doi: 10.5694/mja2.51304. Epub 2021 Oct 24.
10
Reflecting on Plastic Surgery Training During Early COVID-19 Pandemic: Resident Exposure and Telemedicine.
J Craniofac Surg. 2022 Sep 1;33(6):1820-1824. doi: 10.1097/SCS.0000000000008471. Epub 2022 Jun 28.
引用本文的文献
1
Comprehensive DNA methylation profiling of COVID-19 and hepatocellular carcinoma to identify common pathogenesis and potential therapeutic targets.
Clin Epigenetics. 2023 Jun 12;15(1):100. doi: 10.1186/s13148-023-01515-8.
本文引用的文献
1
Addressing the Long-term Effects of COVID-19.
JAMA. 2022 Sep 6;328(9):823-824. doi: 10.1001/jama.2022.14089.
2
Covid-19 and radiotherapy: a systematic review after 2 years of pandemic.
Clin Transl Imaging. 2022;10(6):611-630. doi: 10.1007/s40336-022-00513-9. Epub 2022 Jul 23.
3
Severe acute hepatitis in children: investigate SARS-CoV-2 superantigens.
Lancet Gastroenterol Hepatol. 2022 Jul;7(7):594-595. doi: 10.1016/S2468-1253(22)00166-2. Epub 2022 May 14.
4
Health outcomes in people 2 years after surviving hospitalisation with COVID-19: a longitudinal cohort study.
Lancet Respir Med. 2022 Sep;10(9):863-876. doi: 10.1016/S2213-2600(22)00126-6. Epub 2022 May 11.
5
Omicron - The new SARS-CoV-2 challenge?
Rev Med Virol. 2022 Jul;32(4):e2358. doi: 10.1002/rmv.2358. Epub 2022 Apr 21.
6
Risks of deep vein thrombosis, pulmonary embolism, and bleeding after covid-19: nationwide self-controlled cases series and matched cohort study.
BMJ. 2022 Apr 6;377:e069590. doi: 10.1136/bmj-2021-069590.
7
Prospective Evaluation of Autonomic Dysfunction in Post-Acute Sequela of COVID-19.
J Am Coll Cardiol. 2022 Jun 14;79(23):2325-2330. doi: 10.1016/j.jacc.2022.03.357. Epub 2022 Apr 2.
8
Antigenic evolution will lead to new SARS-CoV-2 variants with unpredictable severity.
Nat Rev Microbiol. 2022 May;20(5):251-252. doi: 10.1038/s41579-022-00722-z.
9
Estimating excess mortality due to the COVID-19 pandemic: a systematic analysis of COVID-19-related mortality, 2020-21.
Lancet. 2022 Apr 16;399(10334):1513-1536. doi: 10.1016/S0140-6736(21)02796-3. Epub 2022 Mar 10.
10
Telehealth and Artificial Intelligence Insights into Healthcare during the COVID-19 Pandemic.
Healthcare (Basel). 2022 Feb 18;10(2):385. doi: 10.3390/healthcare10020385.
Zotero 插件